Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (NCT07889440) titled 'Conduction Breakthrough in the Coronary Sinus Post Endocardial Mitral Isthmus Ablation' on Oct. 16.

Study Type: Observational [Patient Registry]

Primary Sponsor: Sebastien Knecht

Condition: Atrial Fibrillation (AF) Atrial Tachycardia Paroxysmal AF Persisent Atrial Fibrillation

Recruitment Status: Not recruiting

Date of First Enrollment: October 2026

Target Sample Size: 50

To know more, visit https://clinicaltrials.gov/study/NCT07889440

Disclaimer: Curated by HT Syndication....